. Author manuscript; available in PMC: 2021 Nov 1.

Published in final edited form as: Med Res Rev. 2020 Jul 14;40(6):2339–2385. doi: 10.1002/med.21708

TABLE 4.

Antiviral activity of compounds 32–39 toward BVM-resistant virus

Compound	32	33	34	35	36	37	38	39
V7A/EC₅₀ (μM)	0.009	0.014	0.022	0.026	0.022	0.010	0.008	0.019